The efficacy for type 2 diabetes of repaglinide taking twice or three times a day

Trial Profile

The efficacy for type 2 diabetes of repaglinide taking twice or three times a day

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Jul 2014

At a glance

  • Drugs Repaglinide (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Sep 2012 Actual initiation date changed from 1 Jan 2012 to 15 Jul 2011 as reported by University Hospital Medical Information Network - Japan.
    • 14 Sep 2012 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 16 Dec 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top